Joan H Dunlop1, Corinne A Keet1, Kim Mudd1, Robert A Wood2. 1. Division of Pediatric Allergy and Immunology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md. 2. Division of Pediatric Allergy and Immunology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: rwood@jhmi.edu.
Abstract
BACKGROUND: Clinical trials of baked milk (BM) introduction have demonstrated accelerated resolution of milk allergy. OBJECTIVE: Long-term data regarding real-world introduction of BM are lacking. We sought to characterize our experience of BM introduction. METHODS: We performed a retrospective chart review of consecutive BM oral food challenges performed in our clinic from 2009 to 2014, with a minimum follow-up of 24 months. RESULTS: Of the 206 patients challenged, 99 (48%) passed and 187 were sent home with detailed instructions to incorporate BM into their diets. After a median of 49 months of follow-up, 43% of the 187 had progressed to direct milk, 20% to less-cooked forms of milk, 10% remained ingesting BM, and 28% were strictly avoiding milk. Higher milk IgE levels were associated with decreased odds of passing a BM challenge and advancing to less-cooked forms of milk. Predictors of progressing to less-cooked forms of milk were passing the challenge and younger age. There were 79 reported milk reactions involving 68 patients (33% of total) during follow-up. Of these, 78% were classified as mild, 14% severe, and 6 patients developed eosinophilic esophagitis. Of 11 severe reactions, 4 were accidental exposures, 3 were planned escalations, and 4 occurred with previously tolerated doses. CONCLUSIONS: The majority of patients who underwent a BM challenge, including those who failed their challenge, were able to progress to direct or less-cooked forms of milk. However, adverse reactions were common, and even a successful BM challenge does not guarantee future tolerance of BM or preclude later reactions, even to previously tolerated doses.
BACKGROUND: Clinical trials of baked milk (BM) introduction have demonstrated accelerated resolution of milk allergy. OBJECTIVE: Long-term data regarding real-world introduction of BM are lacking. We sought to characterize our experience of BM introduction. METHODS: We performed a retrospective chart review of consecutive BM oral food challenges performed in our clinic from 2009 to 2014, with a minimum follow-up of 24 months. RESULTS: Of the 206 patients challenged, 99 (48%) passed and 187 were sent home with detailed instructions to incorporate BM into their diets. After a median of 49 months of follow-up, 43% of the 187 had progressed to direct milk, 20% to less-cooked forms of milk, 10% remained ingesting BM, and 28% were strictly avoiding milk. Higher milkIgE levels were associated with decreased odds of passing a BM challenge and advancing to less-cooked forms of milk. Predictors of progressing to less-cooked forms of milk were passing the challenge and younger age. There were 79 reported milk reactions involving 68 patients (33% of total) during follow-up. Of these, 78% were classified as mild, 14% severe, and 6 patients developed eosinophilic esophagitis. Of 11 severe reactions, 4 were accidental exposures, 3 were planned escalations, and 4 occurred with previously tolerated doses. CONCLUSIONS: The majority of patients who underwent a BM challenge, including those who failed their challenge, were able to progress to direct or less-cooked forms of milk. However, adverse reactions were common, and even a successful BM challenge does not guarantee future tolerance of BM or preclude later reactions, even to previously tolerated doses.
Authors: Lara S Ford; Katherine A Bloom; Anna H Nowak-Węgrzyn; Wayne G Shreffler; Madhan Masilamani; Hugh A Sampson Journal: J Allergy Clin Immunol Date: 2012-07-20 Impact factor: 10.793
Authors: Jennifer S Kim; Anna Nowak-Węgrzyn; Scott H Sicherer; Sally Noone; Erin L Moshier; Hugh A Sampson Journal: J Allergy Clin Immunol Date: 2011-05-23 Impact factor: 10.793
Authors: Anna Nowak-Wegrzyn; Katherine A Bloom; Scott H Sicherer; Wayne G Shreffler; Sally Noone; Niya Wanich; Hugh A Sampson Journal: J Allergy Clin Immunol Date: 2008-07-11 Impact factor: 10.793
Authors: John Leung; Navneet Virk Hundal; Aubrey J Katz; Wayne G Shreffler; Qian Yuan; Carolyn A Butterworth; Paul E Hesterberg Journal: J Allergy Clin Immunol Date: 2013-09-29 Impact factor: 10.793
Authors: A A Schoemaker; A B Sprikkelman; K E Grimshaw; G Roberts; L Grabenhenrich; L Rosenfeld; S Siegert; R Dubakiene; O Rudzeviciene; M Reche; A Fiandor; N G Papadopoulos; A Malamitsi-Puchner; A Fiocchi; L Dahdah; S Th Sigurdardottir; M Clausen; A Stańczyk-Przyłuska; K Zeman; E N C Mills; D McBride; T Keil; K Beyer Journal: Allergy Date: 2015-05-18 Impact factor: 13.146